Poseida Therapeutics Inc (PSTX)
3.01
+0.09
(+3.08%)
USD |
NASDAQ |
Jul 01, 16:00
3.01
0.00 (0.00%)
After-Hours: 20:00
Poseida Therapeutics Accounts Receivable (Quarterly): 12.03M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 12.03M |
| December 31, 2023 | 9.01M |
| September 30, 2023 | 8.672M |
| June 30, 2023 | 11.91M |
| March 31, 2023 | 8.437M |
| Date | Value |
|---|---|
| December 31, 2022 | 9.088M |
| September 30, 2022 | 38.47M |
| June 30, 2022 | 0.232M |
| March 31, 2022 | |
| December 31, 2021 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2021
38.47M
Maximum
Sep 2022
10.87M
Average
9.01M
Median
Dec 2023
Accounts Receivable (Quarterly) Benchmarks
| Cartesian Therapeutics Inc | 2.006M |
| Biomea Fusion Inc | -- |
| NovaBay Pharmaceuticals Inc | 0.734M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |